Holen Sie sich die Stockscreener-App
3.0756
1.34%
0.0406
Handel nachbörslich:
3.08
0.0044
+0.14%
Schlusskurs vom Vortag:
$3.035
Offen:
$3.11
24-Stunden-Volumen:
7,750
Relative Volume:
0.10
Marktkapitalisierung:
$4.74M
Einnahmen:
$2.54M
Nettoeinkommen (Verlust:
$-4.13M
KGV:
-1.1184
EPS:
-2.75
Netto-Cashflow:
$-4.11M
1W Leistung:
+7.92%
1M Leistung:
-3.89%
6M Leistung:
-20.93%
1J Leistung:
-24.78%
1-Tages-Spanne:
$3.00
$3.18
1-Wochen-Bereich:
$2.79
$3.18
52-Wochen-Spanne:
$2.20
$5.2683
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Firmenname
Xenetic Biosciences Inc
Sektor
Branche
Telefon
781-778-7720
Adresse
945 CONCORD ST., FRAMINGHAM, MA
Vergleichen Sie XBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
3.0756 | 4.69M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-08 | Eingeleitet | Maxim Group | Buy |
Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten
Will Xenetic Biosciences Inc. stock go up soonMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Xenetic Biosciences Inc. stock trend outlook and recovery pathRisk Management & Weekly High Conviction Ideas - Newser
Will Xenetic Biosciences Inc. bounce back from current supportFed Meeting & Real-Time Sentiment Analysis - Newser
Is Xenetic Biosciences Inc. a defensive stock2025 Market Sentiment & Real-Time Volume Analysis - khodrobank.com
Will Xenetic Biosciences Inc. continue its uptrendWeekly Risk Summary & Weekly Setup with High ROI Potential - Newser
When is the best time to exit Xenetic Biosciences Inc.2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
Can trapped investors hope for a rebound in Xenetic Biosciences Inc.Risk Management & Risk Managed Trade Strategies - Newser
Live market analysis of Xenetic Biosciences Inc.Market Risk Summary & Community Consensus Picks - Newser
Can you recover from losses in Xenetic Biosciences Inc.Weekly Stock Analysis & Low Risk Profit Maximizing Plans - Newser
Short interest data insights for Xenetic Biosciences Inc.Market Movement Recap & AI Powered Market Entry Strategies - Newser
Custom watchlist performance reports with Xenetic Biosciences Inc.Earnings Miss & Weekly High Conviction Trade Ideas - Newser
Will Xenetic Biosciences Inc. outperform tech stocksQuarterly Portfolio Summary & Verified High Yield Trade Plans - khodrobank.com
Is Xenetic Biosciences Inc. a strong candidate for buy and holdJuly 2025 Market Mood & Weekly Top Stock Performers List - khodrobank.com
Can Xenetic Biosciences Inc. expand into new marketsWeekly Investment Report & AI Forecast for Swing Trade Picks - khodrobank.com
Visual analytics tools that track Xenetic Biosciences Inc. performanceJuly 2025 Rallies & Detailed Earnings Play Strategies - Newser
Published on: 2025-09-02 14:47:54 - Newser
Xenetic Biosciences Inc.’s volatility index tracking explainedBear Alert & Daily Entry Point Trade Alerts - Newser
Momentum divergence signals in Xenetic Biosciences Inc. chartEarnings Recap Summary & AI Driven Stock Price Forecasts - Newser
Does Xenetic Biosciences Inc. offer margin of safetyMarket Risk Analysis & Real-Time Price Movement Reports - khodrobank.com
Analyzing drawdowns of Xenetic Biosciences Inc. with statistical toolsJuly 2025 Market Mood & High Yield Stock Recommendations - Newser
What Fibonacci levels say about Xenetic Biosciences Inc. reboundCEO Change & Low Risk High Win Rate Stock Picks - Newser
What’s the analyst consensus on Xenetic Biosciences Inc.2025 Big Picture & Low Drawdown Trading Techniques - khodrobank.com
Does Xenetic Biosciences Inc. meet Warren Buffett’s criteriaTrade Entry Report & Safe Entry Trade Reports - khodrobank.com
Technical analysis overview for Xenetic Biosciences Inc. stock2025 Macro Impact & Weekly Momentum Stock Picks - Newser
Xenetic Biosciences Inc. Uptrend in Early Stages Indicators Say Yes2025 Fundamental Recap & Fast Gaining Stock Strategy Reports - beatles.ru
Will Xenetic Biosciences Inc. Benefit From Broader Market Bounce getLinesFromResByArray error: size == 0 - news-j.co.kr
Xenetic Biosciences Inc. Builds Base for Possible ReboundWeekly Gains Summary & Low Volatility Stock Suggestions - beatles.ru
Xenetic Biosciences Inc. stock volume spike explainedJuly 2025 Summary & Real-Time Stock Price Movement Reports - Newser
Is Xenetic Biosciences Inc. stock a smart retirement pick getLinesFromResByArray error: size == 0 - sisain.net
Short Covering May Lift Xenetic Biosciences Inc. in Near Term getLinesFromResByArray error: size == 0 - 더경남뉴스
Can momentum traders help lift Xenetic Biosciences Inc.July 2025 Sentiment & Low Drawdown Momentum Trade Ideas - Newser
Has Xenetic Biosciences Inc. found a price floor2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
What recovery options are there for Xenetic Biosciences Inc.Chart Signals & Daily Market Momentum Tracking - Newser
What to do if you’re stuck in Xenetic Biosciences Inc.Global Markets & Smart Swing Trading Alerts - Newser
Is It Too Early to Call Recovery in Xenetic Biosciences Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Can Xenetic Biosciences Inc. expand into new markets getLinesFromResByArray error: size == 0 - sisain.net
Price momentum metrics for Xenetic Biosciences Inc. explainedTrade Exit Report & Free AI Powered Buy and Sell Recommendations - Newser
Evaluating Xenetic Biosciences Inc. with trendline analysisShare Buyback & Free Expert Approved Momentum Trade Ideas - Newser
Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):